Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Adaptive resistance: a tumor strategy to evade immune attack.

Yao S, Chen L.

Eur J Immunol. 2013 Mar;43(3):576-9. doi: 10.1002/eji.201243275. Epub 2013 Feb 4.

2.

Do effector and memory T helper cells also need B7 ligand costimulatory signals?

Gause WC, Mitro V, Via C, Linsley P, Urban JF Jr, Greenwald RJ.

J Immunol. 1997 Aug 1;159(3):1055-8. Review.

PMID:
9233595
3.

The B7 family revisited.

Greenwald RJ, Freeman GJ, Sharpe AH.

Annu Rev Immunol. 2005;23:515-48. Review.

PMID:
15771580
4.

Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation?

Thompson CB.

Cell. 1995 Jun 30;81(7):979-82. Review. No abstract available.

5.

The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses.

Carreno BM, Collins M.

Annu Rev Immunol. 2002;20:29-53. Epub 2001 Oct 4. Review.

PMID:
11861596
6.

Helper T cell anergy: from biochemistry to cancer pathophysiology and therapeutics.

Appleman LJ, Tzachanis D, Grader-Beck T, van Puijenbroek AA, Boussiotis VA.

J Mol Med (Berl). 2001;78(12):673-83. Review.

PMID:
11434720
7.

The expanding B7 superfamily: increasing complexity in costimulatory signals regulating T cell function.

Coyle AJ, Gutierrez-Ramos JC.

Nat Immunol. 2001 Mar;2(3):203-9. Review.

PMID:
11224518
8.

Immune regulation by novel costimulatory molecules.

Dong C, Nurieva RI, Prasad DV.

Immunol Res. 2003;28(1):39-48. Review.

PMID:
12947223
9.

Novel "Elements" of Immune Suppression within the Tumor Microenvironment.

Gurusamy D, Clever D, Eil R, Restifo NP.

Cancer Immunol Res. 2017 Jun;5(6):426-433. doi: 10.1158/2326-6066.CIR-17-0117. Review.

PMID:
28576921

Supplemental Content

Support Center